In February 2013, TargetCancer awarded its largest grant distribution since being founded in 2009:
• $60,000 supporting Dr. Nabeel Bardeesy and his comprehensive cholangiocarcinoma research program at the Massachusetts General Hospital Cancer Center, marking the third year of an ongoing commitment to create the most extensive existing research program for that disease.
• $30,000 to support the second year of the TargetCancer Cholangiocarcinoma Cell Line Bank at Massachusetts General Hospital, a unique and innovative program that has expanded significantly since being founded last year.
• $35,000 in support of Dr. Adam Bass' research into esophageal cancer at the Dana-Farber Cancer Institute, focusing on the identification of a molecular signature for that disease as recently published in Nature Genetics, and described in more detail here.
A Busy Year!
In 2012, TargetCancer held 7 fundraisers that attracted over 1,200 attendees and raised more than $160,000!
Please see the below slideshow for highlights from all of our events in 2012.
|Join Our Mailing List|